ELI LILLY & Co SEC filings LLY

ELI LILLY & Co has 1,001 filings in SEC EDGAR's recent list, going back to Feb 3, 2022. Its latest annual report, Form 10-K, was filed on Feb 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Mar 20, 2026 —
DEF 14A Proxy statement Mar 20, 2026 Mar 20, 2026
PRE 14A Preliminary proxy statement Mar 6, 2026 Mar 6, 2026
DEFA14A Additional proxy material Mar 21, 2025 —
DEF 14A Proxy statement Mar 21, 2025 Mar 21, 2025
PRE 14A Preliminary proxy statement Mar 7, 2025 Mar 7, 2025
DEFA14A Additional proxy material Mar 22, 2024 —
DEF 14A Proxy statement Mar 22, 2024 Mar 22, 2024
PRE 14A Preliminary proxy statement Mar 8, 2024 Mar 8, 2024
DEFA14A Additional proxy material Mar 17, 2023 —
DEF 14A Proxy statement Mar 17, 2023 —
PRE 14A Preliminary proxy statement Feb 24, 2023 —
DEFA14A Additional proxy material Mar 18, 2022 —
DEF 14A Proxy statement Mar 18, 2022 Mar 18, 2022
PRE 14A Preliminary proxy statement Feb 25, 2022 Feb 25, 2022

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LLY (NYSE)
Fiscal year ends
December 31
Incorporated in
IN
Headquarters
Indianapolis, IN
SEC filer status
Large accelerated filer
SEC CIK
59478
Former names
LILLY ELI & CO (until Oct 25, 2019); LILLY ELI & CO ET AL (until Oct 14, 1994)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.